Dyslipidemia Management
Relevant Content
Key Patient Messages: 2025 Acute Coronary Syndromes Guideline
Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA‐MI Trial
When the blood flow to the heart is suddenly slowed or stopped this is cal...
IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes
Circulation, Ahead of Print.
BACKGROUND:We report IMPROVE-DiCE (Impro...
State of the Art: Evaluation and Medical Management of Nonobstructive Coronary Artery Disease in Patients With Chest Pain
BACKGROUND:We report IMPROVE-DiCE (Impro...
Non-obstructive coronary artery disease (NOCA) is common, carries signific...
Association of Non‐Insulin‐Based Insulin Resistance Indices With Risk of Incident Valvular Heart Disease: Results From the UK Biobank Cohort Study
Journal of the American Heart Association, Ahead of Print.
Background...
Science News from #EPI|Lifestyle25
Background...
Exclusive interviews from keynote speakers, presenters and award-winning c...
Cardiovascular Kidney Metabolic Health: A Presidential Advisory From the AHA
General Cardiology ... Gerontology ... Imaging and Nuclear Medicine Interventional Cardiology Metabolism and Physiology Nutrition Science Prevention Health and Wellness
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
Explore the Science News coverage for the 2025 ACC/AHA/ACEP/NAEMSP/SCAI Gu...
2018 Prevention Guidelines Tool CV Risk Calculator
Journal of the American Heart Association, Ahead of Print.
Background...
Metabolic Dysfunction–Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population‐Based Study
Background...
Journal of the American Heart Association, Ahead of Print.
Background...
Background...
